OpenAlex
PricingAboutJobs
Log inGet started
Work

Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial

HTML PDF

Year: 2022
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Nature Medicine
DOI: 10.1038/s41591-022-01936-7
Authors: Stephen J. Nicholls, Marc Ditmarsch, John J. Kastelein, Scott P. Rigby, Douglas Kling, Danielle L. Curcio, Nicholas John Alp, Michael H. Davidson
Institutions: Monash University, NewAmsterdam Pharma (Netherlands), Amsterdam UMC Location University of Amsterdam, Medpace (United States)
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: obicetrapib, cholesteryl ester transfer protein inhibitors, high-intensity statins, LDL cholesterol lowering, dyslipidemia, apolipoprotein B, non-HDL cholesterol, HDL cholesterol, lipid-lowering therapy, high cardiovascular risk, drug safety
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W4292242012
FWCI: 23.17
Cites: 34
Cited by: 187
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security